#17 – Psychedelic Capitalists Part 2: Pandemic Profiteers and Non-Cooperative Actors
Brian, Dave, and Russell continue their conversation about neoliberals in psychedelia, including companies using the coronavirus pandemic to promote psychedelics for mental health. They also deconstruct non-profit vs. for-profit rhetoric and propose more pragmatic frameworks for examining the implications (and material realities) of psychedelic corporations and their operating structures, such as cooperative vs. non-cooperative.
Watch
Episode links
Calm Down. What’s the Worst Thing That the Wellness Industry Could Do To Psychedelics?
Talking Psychedelic Capitalism In a WeWork Ballroom
Christian Angermayer’s ATAI Life Sciences is Positioned to Take the Psychedelic Throne From MAPS
Making Psychedelics Boring Again: Unless You’re a Privileged Psychedelic Executive, Of Course
Psychedelic Trade Secrets and Get-Rich-Quick Schemes — A Benefit to Investors, a Harm to Progress
Never Forget: Before There Was A Mush Rush, There Was A Plea For Decency
Plus Three goes deep into the world of drugs, from local decriminalization and emerging psychedelic corporations, to leftist politics and mass incarceration. Each week we attempt to make sense of the complex connections between drugs, science, capitalism, policy, and culture.
Psymposia is a 501(c)(3) non-profit media organization. We depend on contributions from our readers and listeners, never ads. If you like the show please donate or support us on Patreon. Patreon supporters get bonus videos and more.